Skip to main content
Clinical Trials/NCT03372330
NCT03372330
Unknown
Not Applicable

Prevalence and Outcomes of Peripheral Artery Disease in Sepsis Patients in the Medical Intensive Care Unit

National Taiwan University Hospital Hsin-Chu Branch1 site in 1 country200 target enrollmentSeptember 11, 2017

Overview

Phase
Not Applicable
Intervention
Standard care for sepsis and PAD
Conditions
Peripheral Artery Disease
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Enrollment
200
Locations
1
Primary Endpoint
All-cause mortality at 30-day
Last Updated
8 years ago

Overview

Brief Summary

The peripheral artery disease (PAD) prevalence is high in the elderly, the diabetic patients, and the patients receiving hemodialysis. To date, there is no guideline recommendation on the screening of PAD in patients admitted to the medical intensive care unit (MICU) for sepsis.

We conducted a prospective cohort study focusing on patients admitted to the MICU with the main diagnosis of sepsis. The ankle-brachial indexes are performed within 24 hours after admission. Invasive arterial line monitoring and standard non-invasive measurements are collected. After confirmation of PAD, standard anti-platelet treatments (aspirin and cilostazol) are initiated. The survival before and after the conduction of this trial is compared to historical records. The outcomes including all-cause mortality, stroke, myocardial infarction, minor amputation, major amputation, and prolonged ventilator dependent are to be collected.

Detailed Description

This is a prospective observational study focusing on peripheral artery disease (PAD) in patients admitting to intensive care units with a diagnosis of sepsis. The sepsis is defined by the quick SOFA score. The primary outcome is all-cause mortality. The secondary outcomes included stroke, myocardial infarction, amputation, and prolonged mechanical ventilation. We plan to enroll 150 patients. Patients will be grouped into patients with PAD and patients without PAD. We then compare them in the following parameters: clinical data, laboratory data, survival and other outcome data. Two-sample student's t-tests will be used for the comparisons of continuous variables. Chi-square test will be used to detect the difference between categorical variables. The difference is considered statistically significant if P \< 0.05. All statistics works were analyzed using the SPSS 17.0 software (Chicago, IL, USA), R software (Gimc packages).

Registry
clinicaltrials.gov
Start Date
September 11, 2017
End Date
September 10, 2019
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • sepsis patients admitted to the MICU meeting quick SOFA score \>= 2 points

Exclusion Criteria

  • Not provided

Arms & Interventions

Sepsis with PAD

Patients admitted to the intensive care unit with the diagnosis of sepsis (quick SOFA score \>=2) and with ankle-brachial index \< 0.9 or vascular Duplex confirmed peripheral artery disease. \* Standard care for sepsis and PAD

Intervention: Standard care for sepsis and PAD

Sepsis without PAD

Patients admitted to the intensive care unit with the diagnosis of sepsis (quick SOFA score \>=2) and with ankle-brachial index \>= 0.9 or vascular Duplex found no evidence of peripheral artery disease. \* Standard care for sepsis

Intervention: Standard care for sepsis

Outcomes

Primary Outcomes

All-cause mortality at 30-day

Time Frame: 30 days

All-cause mortality at 30 days

Secondary Outcomes

  • Myocardial infarction(30 days)
  • Stroke(30 days)
  • Amputation(30 days)

Study Sites (1)

Loading locations...

Similar Trials